论文部分内容阅读
In the process of selecting customized therapeutic lead antibody candidates from large antibody libraries, various process challenges have to be met in terms of screening, manufacturing and analytics.The process design needs to ideally serve multiple requirements from the early research phase, where high-throughput methods for lead selection are required through early clinical development, where scaleable and robust methods need to provide high quality clinical trial material (and analytical data) within attractive time frames.